Image 1 of 1
KLOW is a multi-peptide research formulation composed of TB-500 (10mg), BPC-157 (10mg), GHK (50mg), and KPV (10mg). This blended 80mg vial is engineered for laboratory studies investigating combined peptide interactions across cellular signaling, tissue-modulation pathways, and molecular regulatory responses.
In controlled research environments, KLOW is examined for:
• Multi-pathway cellular signaling relationships
• Peptide-mediated modulation of tissue environments
• Inflammatory response signaling models
• Complementary molecular activity between TB-500, BPC-157, GHK, and KPV
• Variable stability due to differing half-lives among component peptides
• Renal and enzymatic clearance behavior
Each component is lyophilized and sealed within a sterile vial to preserve structure and maintain batch consistency. The blend is stored under appropriate laboratory peptide conditions to ensure stability and reproducible research outcomes.
Research Disclaimer:
For laboratory, in-vitro, and developmental research use only. Not for human consumption. Not for clinical, veterinary, or diagnostic use. The statements on this page have not been evaluated by the FDA.
